Title Credit Type Event date Costsort descending
Evolution of Progression: An Expert Forum on Advancements in Monitoring and Treating Multiple Sclerosis (Credit Expired) Enduring $0.00
The Age of Disease Modification in Alzheimer’s Disease: A Grand Rounds Series on the Practical Implementation of Amyloid Targeting Therapies into...
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Attendance
Live 06/19/2025 - 1:00pm EDT $0.00
The ARIA Toolkit: An Interdisciplinary Curriculum to Optimize Team-Based Management of Amyloid-Related Imaging Abnormalities in Alzheimer’s Disease Enduring $0.00
Alzheimer’s Disease Diagnosis Time Outs: A Deep Dive into Challenging Clinical Scenarios for Early Alzheimer's Diagnosis and Treatment
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Attendance
Enduring $0.00
Decoding CIDP Strategies to Overcome Common Diagnostic and Therapeutic Pitfalls Enduring $0.00
Navigating the Clinic: Applying Modern Evidence, Expert Insights, and Practice Simulations to Optimize Idiopathic Hypersomnia Management Enduring $0.00
The Path to Least Resistance: The Emerging Role of Noncovalent BTK Inhibitors in CLL/SLL Across Clinical Practice Settings
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 AAPA Category I CME
Enduring $0.00
Broadening the Treatment Horizon: Examining the Expanding Roles of New Therapies in Epilepsy Management (Credit Expired) Enduring $0.00
Lost in Transition: Pearls From An Interactive Workshop to Improve the Journey to Adulthood in Spinal Muscular Atrophy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 AAPA Category I CME
    • 0.50 Attendance
Enduring $0.00
Inside Myasthenia Gravis: Where Providers and Patients Diverge on Defining Treatment Success Enduring $0.00
Across the Spectrum: Transforming the Detection and Management of Disease State Transitions Across the Spectrum of Multiple Sclerosis (Credit Expired) Enduring $0.00
Part 3: Evolving Roles in Alzheimer’s Disease Management: Team-Based Care in the Modern Age of Disease-Modifying Therapy Enduring $0.00
Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease Enduring $0.00
Part 1: Suspicion, Identification, and Evaluation of Patients Who May Have Early Alzheimer’s Disease Neurobiology Enduring $0.00
From the Ground Up: Evolving Strategies in the Identification and Team-based Management of Patients with Early-Stage Alzheimer’s Disease Neurobiology Enduring $0.00

Pages